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Abstract
This review summarises current knowledge about the effect of oxygen on cytochrome oxidase activity in vitro and in vivo.
Cytochrome oxidase normally operates above its Km for oxygen in vivo. However, decreases in the intracellular oxygen
concentration (hypoxia) under physiological extremes, or during pathophysiology, can cause mitochondrial respiration to
become oxygen limited. Inhibitors that raise the enzyme’s Km will induce oxygen limitation under apparently normoxic
conditions. It is known that the concentrations of nitric oxide and peroxynitrite are raised in a number of pathophysiological
conditions. These compounds are capable of reversibly and irreversibly raising the cytochrome oxidase Km for oxygen.
Therefore, measurements of cell and mitochondrial respiration in vitro that fail to systematically vary oxygen through the
range of physiological concentrations are likely to underestimate the effects of nitric oxide and peroxynitrite in vivo. ß 2000
Elsevier Science B.V. All rights reserved.
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1. Introduction
Mitochondrial pathology is frequently assayed in
vitro. One common method is to measure the respi-
ration rate of whole cells or mitochondria. Alterna-
tively, individual enzyme activities can be deter-
mined. However, it is not always straightforward to
extrapolate conclusions from these studies to the in
vivo condition. For example, as demonstrated by
metabolic control theory [1], the enzyme under study
may not limit mitochondrial function in vivo.
Equally importantly, the in vitro conditions may
not mimic adequately the in vivo situation. For in-
stance it is technically di⁄cult to make measure-
ments at low oxygen tensions, yet these are exactly
the conditions the cell has to operate under. The
purpose of this article is to brie£y review data relat-
ing to the physiological intracellular oxygen tension.
Whether this pO2 a¡ects mitochondrial function
under normal conditions will then be analysed. Fi-
nally recent data demonstrating that nitrogen oxides
can permanently increase the mitochondrial Km for
oxygen will be presented. It will become clear that
assays of mitochondrial function that fail to system-
atically vary the oxygen concentration throughout
the whole of the physiological and pathophysiologi-
cal range are likely to seriously underestimate the
amount of mitochondrial damage occurring.
2. The in vivo oxygen concentration
In mammals oxygen is transported to tissues via
the arterial blood supply. Under normal conditions
haemoglobin is fully oxygen saturated, resulting in
an e¡ective oxygen concentration of the order of 10
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mM. The closer the oxygen gets to mitochondrial
cytochrome oxidase the lower its concentration be-
comes. Many di¡erent techniques are available for
measuring directly or indirectly the extracellular in
vivo oxygen concentration including 19F-NMR [2],
blood oxygenation level dependent (BOLD) MRI [3],
EPR [4], near infrared spectroscopy (NIRS) [5],
phosphorescence quenching of porphyrinic probes
[6] and tissue oxygen electrodes [7]. Intracellular
measurements are more di⁄cult, and usually rely
on the presence of intrinsic oxygen sensitive chromo-
phores, e.g., myoglobin [8]. The general conclusion
regarding cellular respiration from these studies is
that the oxygen concentration at cytochrome oxidase
is likely to be much lower than that generally used
during in vitro assays. In particular myoglobin satu-
ration levels in working heart and skeletal muscle
suggest that the intracellular oxygen concentration
is in the region of 3 WM [8]. Oxygen gradients around
mitochondria [9,10], if they exist [11], could further
reduce the oxygen concentration ‘seen’ by cyto-
chrome oxidase.
3. Does oxygen a¡ect cellular respiration in vivo?
Does the relatively low intracellular oxygen ten-
sion a¡ect mitochondrial function in vivo? This is
clearly the case in pathophysiology (e.g., following
cardiac arrest and stroke) where oxygen delivery to
tissues is severely compromised. It is also true for
normal physiology in skeletal muscle. During incre-
mental aerobic exercise oxygen delivery to muscle is
the factor that limits the ¢nal steady state work rate
that can be maintained [12]. Whole body oxygen
consumption plateaus at the so-called VO2 max where
cardiac output is limiting [13]. This is the reason why
elite aerobic athletes (e.g., marathon runners/long
distance cyclists) are tempted to increase their oxygen
delivery by increasing the haematocrit, either legally
(by altitude training) or illegally (via blood doping or
erythropoietin injections).
The situation for the normal physiology of other
tissues is less clear. In assays of puri¢ed cytochrome
oxidase, oxygen limitation will be re£ected simulta-
neously by a drop in the overall oxygen consumption
rate and an increase in the redox state of the relevant
metal centres (e.g., cytochrome c, cytochrome a3).
However, the situation is less clear in vivo. The cel-
lular oxygen consumption rate of cells is controlled
by a number of factors [14,15]. Therefore, as one
would expect from metabolic control theory, a fall
in cytochrome oxidase activity will not have a pro-
portional e¡ect on the cell (or tissue) oxygen con-
sumption rate. The situation is further complicated
by the fact that the ultimate product of the electron
transfer chain (the proton-motive force) directly af-
fects the cytochrome oxidase Km for oxygen. Drop-
ping the oxygen concentration can reduce the proton
electrochemical potential across the inner mitochon-
drial membrane. Energised mitochondria have a
higher oxygen Km than de-energised mitochondria
[16^19]; therefore as de-energisation occurs the oxy-
gen Km will decrease (for a more complete theoretical
treatment of this phenomenon see [16,20,21]). The
mitochondrial oxygen consumption rate can thus be
relatively resistant to oxygen a¡ects at cytochrome
oxidase. However, the redox state of the metal
centres themselves may ‘sense’ an early change in
oxygen concentration. In fact changes in the redox
state of cytochrome oxidase haem a3 have been sug-
gested to play a physiological role in oxygen sensing
in the carotid body [22].
Therefore, in contrast to the puri¢ed detergent-
solubilised enzyme, in the cell/tissue the redox state
of the individual metal centres in the cytochrome c
oxidase reaction may respond to a change in the
oxygen concentration that is not re£ected in the
overall oxygen consumption rate. One study sug-
gested that the cytochrome c redox state was sensi-
tive to oxygen concentrations as high as 240 WM,
under conditions where the Km for oxygen consump-
tion was less than 1 WM [23]. However, other studies
have suggested that the cytochrome c and cyto-
chrome oxidase redox states are insensitive to small
changes in the oxygen concentration around the
physiological pO2 [24,25].
Most, but not all [26], of these early studies fo-
cused on mitochondria or cells. However, there is
large literature on the relationship between the rate
of tissue oxygen delivery to that of tissue oxygen
consumption in whole animals. In many tissues small
changes in the rate of oxygen delivery have no e¡ect
on the oxygen consumption rate until a critical
threshold is reached [27]. However, for the reasons
discussed above, this does not prove that cytochrome
BBABIO 44931 7-8-00
C.E. Cooper, N.A. Davies / Biochimica et Biophysica Acta 1459 (2000) 390^396 391
oxidase is not a¡ected by oxygen concentrations
within the physiological range in the brain. To an-
swer that question measurements of the enzyme re-
dox states are required. Fortunately one non-invasive
technique, near infrared spectroscopy (NIRS), can
measure changes in the redox state of cytochrome
oxidase in the whole brain. This is because NIR light
passes into cerebral tissues [5] and cytochrome oxi-
dase contains a unique NIR absorbing CuA dimer
[28]. The CuA centre is in rapid equilibrium with
cytochrome c (and senses a similar electrochemical
potential [29]). One would therefore expect this
centre to track the changes in the cytochrome c re-
dox state, for which a more substantial in vitro liter-
ature exists [23^25,30,31].
Initial NIR studies suggested that the CuA redox
state in the brain was sensitive to changes in the
oxygen tension around the physiological level
[32,33]. However, it is not trivial to measure the
CuA redox state in the presence of the larger concen-
tration of NIR absorbing oxy- and deoxyhaemoglo-
bin in the brain. We have developed an algorithm
that takes into account the non-linear wavelength
dependence of the optical pathlength in the brain
[34]. Tests with mitochondrial inhibitors suggested
that interference from haemoglobin absorbance
(‘cross-talk’) was negligible [35]. In contrast to the
previous studies, measurements using this ‘second
generation’ algorithm revealed that the cytochrome
oxidase CuA redox state was insensitive to oxygen-
ation changes around the physiological range [36].
Only when blood £ow to the brain was reduced be-
low a critical level was an increased reduction of CuA
observed [37].
These ¢ndings are corroborated by studies on ani-
mal models where blood is replaced with arti¢cial
per£uorocarbon emulsions. Although oxygen deliv-
ery is slightly lower than for an animal with a normal
blood supply, the increased oxygen solubility of these
solutions can still maintain the brain su⁄ciently oxy-
genated so as to not compromise EEG activity.
These animals have the advantage that there is no
possibility of spectral interference from the haemo-
globin ^ the anoxic minus normoxic di¡erence spec-
trum is essentially identical to a mitochondrial
reduced minus oxidised di¡erence spectrum [35,
38,39]. In agreement with our studies in ‘normal’
animals, decreases in the inspired oxygen fraction
in these ‘bloodless’ animals had no initial e¡ect on
the CuA redox state [40]. Therefore cytochrome oxi-
dase is not a¡ected by small decreases in oxygen
delivery to the brain. Of course, when the inspired
oxygen fraction is dropped su⁄ciently, one starts to
see an increased reduction of the CuA centre. Intri-
guingly, one of these studies did demonstrate that
this reduction of CuA preceded the fall in the cerebral
oxygen consumption rate, suggesting that mitochon-
drial redox centres could indeed sense falls in oxygen
tension that did not a¡ect the global oxygen con-
sumption rate [41]. However, it seems that at least
in the brain, this function could only have a role in
pathophysiological, rather than physiological, sens-
ing of oxygen.
Whilst these studies suggest that under ‘normal’
physiology, oxygen concentrations are above the lev-
el that can be sensed by cytochrome oxidase, it is
important to note that the animal studies described
involve anaesthetics and/or analgesics that will tend
to depress the demand for oxygen. When oxygen
consumption is arti¢cially increased in animal mod-
els a di¡erent picture emerges. Adding the uncoupler
dinitrophenol to an animal brain increases the oxy-
gen consumption signi¢cantly. If the rate of oxygen
delivery is dropped even slightly, an immediate re-
duction is seen in the CuA redox state [42]. Thus,
as in the muscle, under conditions of high demand
for oxygen, the delivery of oxygen to cytochrome
oxidase in the brain is poised at a critical level only
just above that which a¡ects enzyme function.
4. E¡ect of nitrogen oxides on the oxygen Km
We have previously demonstrated that nitric oxide
raises the cellular Km for oxygen by reversible com-
petitive inhibition of cytochrome oxidase [43]. This
e¡ect has been well characterised in vitro by our-
selves [44^46] and others [47^51]. Given the delicate
balance between oxygen delivery and cytochrome ox-
idase function described above, it seems likely that
even small levels of nitric oxide interacting with cy-
tochrome oxidase will perturb the function of the
respiratory chain. For example, in rat brain synapto-
somes we calculated an apparent IC50 for nitric oxide
of 60 nM at an oxygen tension of 30 WM [43]. As
discussed previously, intracellular oxygen concentra-
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tions are expected to be 4^5 times lower than this
and therefore the IC50 for NO in vivo is likely to
be as low as 5 nM. This is well within the measured
physiological concentration range of NO.
It is therefore clear that cytochrome oxidase must
have a strategy for dealing with NO in vivo. This
strategy di¡ers depending on the redox state of the
binuclear haem a3/CuB centre. We have shown that
oxidised CuB can rapidly oxidise NO to nitrite [44].
This results in an enzyme with nitrite in the binuclear
centre cavity [45]. This enzyme is still inhibited and
cannot react with oxygen. However, we have recently
shown (Cooper, Wilson, Torres, unpublished obser-
vations) that in the presence of external reductants
the nitrite is driven out of the cavity into the external
medium. Once removed from the enzyme interior,
nitrite is a very poor inhibitor of cytochrome oxidase
(Ki in the mM range). The reaction at oxidised CuB
therefore converts a strong inhibitor (NO) into a
weak one (nitrite). This option is not available to
the reduced binuclear centre which binds NO tightly,
forming a ferrous haem nitrosyl complex [46,51,52].
However, the enzyme seems to have evolved a rela-
tively fast o¡ rate [51] for this complex (0.1 s31).
Therefore when the NO concentration drops in
the external solution the enzyme rapidly recovers
activity. This is in contrast to other haem proteins
(e.g., haemoglobin or myoglobin) for which the
o¡ rate of the haem nitrosyl complex is many hours
[53].
Thus it is possible to devise scenarios where small
£uctuations in the levels of NO rapidly and reversible
modulate cellular respiration by binding to, or react-
ing with, cytochrome oxidase [54,55]. However, we
have recently discovered that the situation is not so
benign for other nitrogen oxides. In particular, per-
oxynitrite irreversibly damages the enzyme. Although
this causes a small increase in the Vmax, the predom-
inant e¡ect is to raise the Km for oxygen [56]. High
(s 1 WM) levels of NO itself can also induce this
irreversible e¡ect. The raised Km persists through re-
peated cycles of re-oxygenation and de-oxygenation
and long after the nitrogen oxide in question has
been removed from the solution. The e¡ect is not
restricted to the puri¢ed enzyme. A similar ‘perma-
nent’ raised oxygen Km is observed following NO
and/or peroxynitrite treatment of cells. It is unclear
what is the precise mechanism for these irreversible
e¡ects. However, it is clear from the in vivo work
described above that factors that cause small irre-
versible alterations in the interaction of oxygen
with cytochrome oxidase may have far-reaching
physiological consequences. For example, regions of
the body that are insensitive to small variations in
the oxygen concentration, may become sensitive sub-
sequent to overproduction of nitrogen oxides. This
e¡ect will persist beyond the lifetime of the molecule
in question. It should therefore be detectable in tis-
sues that have been exposed to peroxynitrite in vivo
and we are currently exploring this possibility.
5. Conclusions
There is a large body of literature on the e¡ect of
nitrogen oxides on mitochondrial function. Yet vir-
tually none of these studies measure mitochondrial
function at physiological oxygen concentrations [57^
61]. Even a recent study on the e¡ect of peroxynitrite
on puri¢ed cytochrome oxidase activity only re-
ported Vmax, not Km measurements [62]. Given the
results demonstrated here, it is clear that statements
that cytochrome oxidase is undamaged under these
conditions must therefore be treated with caution.
These results also have more general implications
for assaying cytochrome oxidase activity. When de-
termining the source of a mitochondrial respiratory
chain dysfunction in vivo [63,64], cytochrome oxi-
dase is invariably assayed at saturating cytochrome
c and oxygen concentrations [65]. These are both
situations far removed from the physiological condi-
tion. It has recently been shown for bacterial cyto-
chrome oxidases that varying the internal electron
transfer rates by adjusting the nature of the low
spin haem can raise the oxygen Km [66]. Point muta-
tions (perhaps in an ‘oxygen channel’) can also have
a similar e¡ect [67]. In order to exclude cytochrome
oxidase damage in patients with mitochondrial myo-
pathies in future, it is therefore going to be necessary
to measure the Km for oxygen, as well as the Vmax.
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